🇺🇸 FDA
Pipeline program

VEGF Trap-Eye

VGFT-OD-0512

Phase 1 small_molecule completed

Quick answer

VEGF Trap-Eye for Diabetic Macular Edema is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Diabetic Macular Edema
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials